We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $29B
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+23.54%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$5.72B
AUM Growth
+$1.72B
Cap. Flow
-$1.08B
Cap. Flow %
-18.95%
Top 10 Hldgs %
42.77%
Holding
683
New
195
Increased
120
Reduced
90
Closed
196

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$119M
2
DKNG icon
DraftKings
DKNG
+$63.9M
3
NKLA
Nikola Corporation Common Stock
NKLA
+$49.9M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$45.5M
5
CTEV
Claritev Corp
CTEV
+$42.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$187M
2
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$43.2M
3
TSLA icon
Tesla
TSLA
+$38.7M
4
AMZN icon
Amazon
AMZN
+$37M
5
CFFAU
CF Finance Acquisition Corp. Unit
CFFAU
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 13.08%
2 Communication Services 9.75%
3 Consumer Discretionary 8.87%
4 Financials 5.61%
5 Industrials 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
401
BridgeBio Pharma
BBIO
$16.4B
$326K 0.01%
+10,000
New +$305K
LQDA icon
402
Liquidia Corp
LQDA
$7.52B
$298K 0.01%
+35,487
New +$269K
PCPL.WS
403
DELISTED
CC Neuberger Principal Holdings I Warrants, each whole warrant exercisable for one Class A ordinary
PCPL.WS
$283K 0.01%
+195,847
New +$315K
MAS icon
404
Masco
MAS
$14.7B
$251K ﹤0.01%
+5,000
New +$217K
ENTA icon
405
Enanta Pharmaceuticals
ENTA
$391M
$238K ﹤0.01%
+4,746
New +$246K
HCCHR
406
DELISTED
HL Acquisitions Corp. Right
HCCHR
$235K ﹤0.01%
250,000
– –
ANDAR
407
DELISTED
Andina Acquisition Corp. III Right
ANDAR
$227K ﹤0.01%
990,000
+978,000
+8,150% +$177K
ROIC
408
DELISTED
Retail Opportunity Investments Corp.
ROIC
$226K ﹤0.01%
+20,000
New +$194K
TVTY
409
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$226K ﹤0.01%
+20,000
New +$183K
SWBI icon
410
Smith & Wesson
SWBI
$638M
$215K ﹤0.01%
13,010
-84,565
-87% -$786K
FPRX
411
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$213K ﹤0.01%
35,000
-105,000
-75% -$433K
ESSCW
412
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$200K ﹤0.01%
801,900
+789,900
+6,583% +$90.2K
STEX
413
Streamex Corp
STEX
$83.6M
$180K ﹤0.01%
+2,500
New +$218K
OPENW
414
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$180K ﹤0.01%
+49,997
New +$185K
KBLMW
415
DELISTED
KBL Merger Corp. IV Warrant
KBLMW
$173K ﹤0.01%
560,000
– –
BYU
416
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$171K ﹤0.01%
+365
New +$157K
XRX icon
417
Xerox
XRX
$408M
$170K ﹤0.01%
11,180
– –
GNRSW
418
DELISTED
Greenrose Acquisition Corp. Warrant
GNRSW
$154K ﹤0.01%
+735,125
New +$186K
ESSCR
419
DELISTED
East Stone Acquisition Corporation Right
ESSCR
$153K ﹤0.01%
801,900
+590,100
+279% +$87.3K
ACH
420
Accendra Health
ACH
$96.1M
$152K ﹤0.01%
+20,000
New +$146K
FVAC.WS
421
DELISTED
Fortress Value Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FVAC.WS
$141K ﹤0.01%
+100,000
New +$152K
KBLMR
422
DELISTED
KBL Merger Corp. IV Rights expiring 11/9/2020
KBLMR
$140K ﹤0.01%
560,000
– –
EVSIW
423
DELISTED
Envision Solar International, Inc. Warrant
EVSIW
$140K ﹤0.01%
35,000
– –
GNPX icon
424
Genprex
GNPX
$2.31M
$136K ﹤0.01%
+1
New +$122K
MNK
425
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$134K ﹤0.01%
50,000
-100,000
-67% -$300K
15 16
17
18 19

Similar funds

Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
State of Tennessee, Department of Treasury
State of Tennessee, Department of Treasury Nashville, Tennessee $29.8B AUM 29.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Hudson Bay Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Hudson Bay Capital Management held 683 positions worth $5.72B, up 43% from $3.99B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Hudson Bay Capital Management withdrew a net $1.08B in Q2 2020, closing 196 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Hudson Bay Capital Management opened a new position in Legend Biotech worth $122M.

  • Hudson Bay Capital Management's largest Q2 2020 buy was Legend Biotech: 3,056,342 shares worth $122M.
  • Hudson Bay Capital Management added most to DraftKings in Q2 2020, an estimated $63.9M increase.
  • Hudson Bay Capital Management's biggest Q2 2020 reduction was Tesla, cutting an estimated $38.7M.
  • Hudson Bay Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $187M.
  • Hudson Bay Capital Management's ten largest holdings make up 43% of its $5.72B portfolio in Q2 2020.
  • Hudson Bay Capital Management opened 195 new positions and closed 196 in Q2 2020.
  • Hudson Bay Capital Management's portfolio value rose 43% quarter-over-quarter to $5.72B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.